All News #Library
Biotech
Topas Presents Phase 2a Data for TPM502 at Digestive Week
24 Apr 2025 //
BUSINESSWIRE
Topas Therapeutics Initiates Phase 2a Trial for TPM502 in Celiac Disease
25 May 2023 //
BUSINESSWIRE

Market Place
Sourcing Support